Product
Axi-cel
1 clinical trial
1 indication
Indication
B-cell LymphomaClinical trial
A Phase 2 Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell LymphomaStatus: Recruiting, Estimated PCD: 2025-01-01